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Summary. The protective effects of encapsulation on the survival of Lactobacillus reuteri and the retention of the bacte-
rium’s probiotic properties under simulated gastrointestinal conditions were investigated. Viable counts and the remaining 
probiotic properties of calcium (Ca)-alginate encapsulated (A group), chitosan-Ca-alginate encapsulated (CA group), and 
unencapsulated, free L. reuteri (F group) were determined. Encapsulation improved the survival of L. reuteri subjected to 
simulated gastrointestinal conditions, with the greatest protective effect achieved in the CA group. The degree of cell membrane 
injury increased with increasing bile salt concentrations at constant pH, but the extent of injury was less in the encapsulated than 
in the free cells. Adherence rates were, in descending order: CA (0.524%) > A (0.360%) > F (0.275%). Lactobacillus reuteri 
cells retained their antagonistic activity toward Listeria monocytogenes even after incubation of the lactobacilli under simulated 
gastrointestinal conditions. Displacement of the pathogen by cells released from either of the encapsulation matrices was higher 
than that by free cells. The safety of L. reuteri was demonstrated in an in vitro invasion assay. [Int Microbiol 2015; 18(1):61-69]
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Introduction
Most probiotics belong to strains of lactic acid bacteria (LAB) 
and their positive effects on human health are well established 
[40]. These benefits of LAB include: balancing gut microbio-
ta [38], inhibiting infection by pathogens [11], lowering blood 
cholesterol [20], and reducing the risk of colon cancer [19]. 
For probiotics to exert these and other beneficial effects, they 
must pass safely through the gastrointestinal tract and then 
adhere to and colonize the intestinal canal [42]. However, the 
survival of many microbes exposed to gastric acid and bile 
salts is poor. 
Using encapsulation to immobilize LAB cells can im-
prove their survival under adverse conditions [45]. Encap-
sulation offers many advantages for the encapsulated cells, 
including the maintenance of stability, activity, and high volu-
metric productivity, the improvement of process control, pro-
tection against damage, and a reduced susceptibility to con-
tamination [25,41]. Several encapsulation techniques to im-
prove the survival of microorganisms in dairy products [35] 
and artificial gastrointestinal juice [10] have been tested, with 
Properties of Lactobacillus reuteri chitosan-
calcium-alginate encapsulation under 
simulated gastrointestinal conditions
Hui-Ying Huang,1¶ Yi-Ju Tang,1¶ V. An-Erl King,2 Jen-Wei Chou,3 Jen-Horng Tsen1* 
1Department of Nutrition, China Medical University, Taichung, Taiwan, ROC. 2Department of Food Science and 
Biotechnology, National Chung-Hsing University, Taichung, Taiwan, ROC. 3Division of Gastroenterology and Hepatology, 
Department of Internal Medicine, China Medical University Hospital, College of Medicine, 
China Medical University, Taichung, Taiwan, ROC 
Received 17 January 2014 · Accepted 30 March 2015
Int. MIcrobIol. Vol. 18, 2015 HUANG ET AL.62
alginate encapsulation as one of the most successful [18]. The 
encapsulation of LAB in Ca-alginate beads improved the sur-
vival of the cells under harsh conditions [25,31]. Chitosan has 
also been used as the encapsulation material, especially for 
drug delivery in the gastrointestinal tract, based on its absorp-
tion-enhancing, controlled-release, and bioadhesive proper-
ties [8]. Chito san is obtained from chitin via N-deace tylation 
and the immersion of Ca-alginate beads in chitosan solution 
results in the formation of an outer, protective membrane 
[21]. Many studies have shown that encapsulation of LAB in 
a chitosan-alginate complex is effective in reducing the de-
cline of viable cells exposed to simulated gastric and intesti-
nal juice and improves their survival during refrigerated stor-
age [2,22,24].
In addition to tolerating gastric acid and bile salts, probio-
tics must be able to adhere to gut surfaces, colonize the gut 
together with the resident microbiota, and compete with 
pathogens [11]. The probiotic traits of LAB with respect to 
gastric acid and bile tolerance, adhesiveness, and competition 
with pathogens have been investigated [13,31,49] but these 
studies often failed to examine the influence of sequential acid 
and bile salt exposure, as occurs under physiological condi-
tions in the human gastrointestinal tract [25]. Moreover, few 
studies have considered the remaining probiotic properties of 
LAB cells after their exposure to simulated gastrointestinal 
conditions. In a previous work [16], we found that the expo-
sure of LAB strains to low pH followed by high concentra-
tions of bile salts led to a decline in cell survival. In addition, 
there was a loss of adhesiveness of viable LAB, perhaps due 
to the cell injury caused by the harsh conditions. LAB strains 
that survived sequential incubations at pH 4 and 0.1% bile salt 
had higher adherence rates but a slightly lower rate of patho-
gen displacement than an unexposed LAB strain. In this study, 
Lactobacillus reuteri was encapsulated in Ca-alginate and 
chitosan-Ca-alginate and the protective effects of encapsula-
tion on the survival of cells exposed to sequential acid and 
bile treatments was evaluated and compared. In addition, we 
assessed the adhesiveness, safety, and displacement of Listeria 
monocytogenes by free and encapsulated bacteria subjected to 
simulated gastrointestinal conditions. 
Materials and methods
Bacterial strains and culture conditions. Lactobacillus reuteri 
BCRC 14625 and Listeria monocytogenes BCRC 14847 were purchased 
from the Bioresource Collection and Research Center of the Food Industry 
Research and Development Institute at Hsinchu, Taiwan. Lactobacillus re-
uteri was grown in de Man, Rogosa and Sharpe (MRS) broth or on MRS agar 
medium (Difco). Listeria monocytogenes was cultured with Bacto brain heart 
infusion (BHI; Difco). Both strains were incubated at 37ºC and propagated 
under microaerophilic conditions. The stock cultures were preserved at 
–80ºC in 20% glycerol.
Encapsulation of Lactobacillus reuteri. Bacteria grown at 37ºC 
for 24 h were centrifuged at 4ºC, 8000 ×g for 10 min. The harvested cell pel-
lets were washed and then resuspended in phosphate-buffered saline (PBS). 
The bacterial suspension was mixed with an equal volume of  2% (w/v) sodi-
um alginate (Na-alginate) solution to obtain a cell suspension containing 1.0–
9.9 × 108 colony-forming units (CFU)/ml. The solution was transferred drop-
wise into 0.1 M CaCl2 through the tube of a peristaltic pump, resulting in the 
formation of calcium alginate (Ca-alginate) beads containing L. reuteri cells 
(A group). A suspension of LAB mixed with an equal volume of H2O served 
as the control free cell group (F group). The chitosan-Ca-alginate beads used 
to encapsulate L. reuteri cells were prepared as previously described [23]. 
Briefly, 0.4 g of chitosan (Sigma) was dissolved in 90 ml of distilled water 
(DW) previously acidified with 0.4 ml of glacial acetic acid. The final concen-
tration of chitosan solution was first adjusted to 0.4% (w/v) and then to pH 
5.7–6.0 with 1 N NaOH. The chitosan solution was then filtered and the vol-
ume was increased to 100 ml with DW. Ca-alginate beads containing L. reuteri 
prepared as described above were then immersed in the 0.4% chitosan solution 
and shaken at 100 rpm for 1 min to produce chitosan-coated-Ca-alginate beads 
(CA group). The interactions of the three groups with the pathogen List. mono-
cytogenes were assessed in wells containing Caco-2 cells and pre-adhered, 
FITC-labeled List. monocytogenes. The adherence rate of the pathogen under 
LAB-free conditions was designated as 100%. 
Microscopic observation of bead structure. The microstruc-
tures of the beads and the encapsulated LAB were examined using scanning 
electron microscopy [34]. The Ca-alginate and chitosan-Ca-alginate beads 
were fixed with 2.5% glutaraldehyde at 4ºC for 16 h, washed with PBS, and 
dehydrated in an ethanol gradient (30, 50, 70, 80, 85, 90, 95, and 100% etha-
nol, each for 15 min). The beads were then dried by critical point drying, 
coated with gold, and observed in a JEOL, JSM-7401F (Japan) scanning elec-
tron microscope.
Tolerance of simulated digestive juice. The initial bacterial 
counts were obtained as follows: for the F group, a previously prepared L. re-
uteri suspension was mixed with an equal volume of aseptic water. For the A 
and CA groups, the L. reuteri suspension was mixed with an equal volume of 
Na-alginate solution. The number of cells in 1 ml of each of the three suspen-
sions was counted after 24–48 h of incubation at 37ºC using the standard 
plate count (SPC) method. The data were expressed as the log CFU/ml. The 
initial LAB counts were expected to be the same in the free and encapsulated 
samples. One ml of free L. reuteri cells for the F group and gel beads prepared 
from 1 ml of an equal volume LAB cells and Na-alginate solution for the A 
and CA groups (~40 gel beads for each encapsulation group) were added to 
10 ml of 0.1% peptone water adjusted to pH 2–3 [11]. The samples were 
shaken at 150 rpm at 37°C for 3 h. The acid-treated free cells were centri-
fuged (25°C, 8000 ×g, 10 min) and the pellets then dissolved in 1 ml of 
aseptic water. Acid-treated beads of the A and CA groups were collected and 
drained dry. The dried beads and 1 ml of acid-treated free cells were then 
transferred to 0.1%, 0.5%, or 1% oxgall bile (Sigma) and shaken as described 
for the acid treatment. After bile treatment, the free cells and gel beads were 
treated as previously described and then transferred to 10 ml of simulated 
colon fluid (0.1 M KH2PO4, pH 7.4 ± 0.2), with shaking for 1 h. Under these 
conditions, the gel beads depolymerized, releasing encapsulated L. reuteri. 
Both the free and the released cells were centrifuged, re-suspended in 1 ml of 
aseptic water, and the number of viable cells was determined.
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β-Galactosidase activity of Lactobacillus reuteri after 
simulated digestive juice treatment. The β-galactosidase activity 
of L. reuteri after simulated digestive juice treatment was assayed as de-
scribed previously [32]. Both free and encapsulated LAB cells were treated 
with acid solutions of pH 2 or pH 3, then with 0.1%, 0.5% or 1% bile salt 
solutions, each for 3 h, and then with simulated colon fluid for1 h. The free 
cells and the cells released from the beads were collected by centrifugation, 
washed, and re-dissolved in 1 ml of aseptic water. The cell suspensions were 
then mixed with 4 ml of 0.005 M o-nitrophenyl-β-d-galactopyranoside 
(ONPG; Sigma) and incubated at 37ºC for 10 min to allow color formation. 
After the reaction was stopped by the addition of 2 ml of 0.1 M sodium car-
bonate, the samples were centrifuged at 8000 ×g at 1°C for 10 min to pre-
cipitate and remove the cells. The absorbance of the supernatant was mea-
sured at 420 nm with a spectrophotometer (Hitachi, U-2000, Japan). The 
amount of o-nitrophenol (ONP) formed in the sample was calculated by com-
parison with a standard curve. β-galactosidase activity was expressed as mi-
cromoles of ONP formed per milliliter of cell suspension in 10 min. 
Cell culture. The epithelial-like Caco-2 cell line BCRC 60182, originally 
isolated from a human colon adenocarcinoma [36], was purchased from 
Bioresource Collection and Research Center of the Food Industry Research 
and Development Institute at Hsinchu, Taiwan. The cells were grown in 
Dulbecco’s modified Eagle’s minimal essential medium (DMEM; Biochrom 
AG, Germany) supplemented with 10% (v/v) heat-inactivated (56ºC, 30 min) 
fetal bovine serum (FBS; Biological, Israel) and 1% (v/v) penicillin-strepto-
mycin (stock solution 100 unit/ml; BioSource, USA) and incubated at 37ºC 
in a CO2 incubator (NUAIRE, NU-5500, USA) with a 5% CO2/95% air atmo-
sphere. Subcultured cells were seeded at a concentration of 3 × 105 cells per 
well in a six-well tissue culture plate. The culture medium was replaced every 
other day. Mature monolayers, obtained after 15 days of incubation, were 
used for the following assays [4].
Adhesion assay. At least 1.5 h before the adhesion assay, the DMEM 
medium was aspirated from the wells and the Caco-2 cell monolayer was 
fixed with 0.25% glutaraldehyde for 15 min followed by three washes with 
PBS. Fresh DMEM not containing FBS or antibiotics was added to each well 
[28]. After exposure to the above-described simulated gastrointestinal condi-
tions (pH 3, 0.1% bile salt, and simulated colon fluid), 1 ml of L. reuteri cells 
released from the gel beads or the free L. reuteri cell suspension was added to 
the respective wells and incubated at 37ºC for 2 h in a 5% CO2/95% air atmo-
sphere. The monolayers were then washed five times with PBS to remove 
non-adherent LAB cells [14] and lysed with 1 ml of a 1% Triton X-100 solu-
tion (Sigma) for 5 min to release adherent bacteria. The number of adherent 
LAB released from the surface of the Caco-2 cells was determined by the 
SPC method using plates incubated for 24-48 h at 37°C [17]. The adherence 
rate (%) was calculated as: 
Adherence rate (%) = 
Antagonistic activity of Lactobacillus reuteri against Lis­
teria monocytogenes. A suspension of List. monocytogenes cells pre-
pared from a culture was centrifuged (25ºC, 8000 ×g, 10 min) to pellet the 
cells, which were then washed three times and resuspended in PBS. The sus-
pension was mixed with an equal volume of 2 mg of fluorescein isothiocya-
nate (FITC; Sigma)/ml for 20 min to stain the bacterial cells. Excess fluoro-
chrome was removed by centrifugation of the FITC-labeled bacterial suspen-
sion, discarding the supernatant and washing the cell pellet three times with 
PBS. To test the displacement effect of L. reuteri, 1 ml of FITC-labeled List. 
monocytogenes suspension was added to a well with a fixed Caco-2 cell 
monolayer and incubated for 2 h. One ml of gel-released or free LAB cells 
treated as described for the adhesion assay was added to a well with pre-ad-
herent List. monocytogenes cells. After 2 h of incubation at 37°C, the incuba-
tion medium was discarded and the Caco-2 cell monolayer was washed five 
times with PBS to remove both non-adherent LAB and pathogen cells. The 
adherence of FITC-labeled List. monocytogenes cells to the Caco-2 cell 
monolayer was assessed with a spectrofluorometer (Bio-Tek, FLX-800, 
USA) by recording the fluorescence intensity at 485 nm excitation and 528 
nm emission. The antagonistic activity of L. reuteri was expressed as the ad-
herence rate (%) of the pathogen (non-displaced List. monocytogenes cells) 
as determined by its fluorescence intensity; that is, the greater the antagonism 
of L. reuteri, the greater the displacement of List. monocytogenes. The “LAB-
free” control consisted of FITC-labeled List. monocytogenes adhered to the 
Caco-2 cells and not exposed to competitive LAB. The adherence rate under 
these conditions was defined as 100%. 
Invasion assay. The in vitro safety of L. reuteri was evaluated in an inva-
sion assay as previously reported [44]. The Caco-2 cell monolayer was 
washed twice with PBS and re-incubated for 1.5 h in fresh DMEM medium 
without penicillin and streptomycin. Gel-released and free LAB cells, both 
pre-treated with simulated gastrointestinal conditions, were suspended in 
antibiotic-free DMEM medium. One ml of LAB suspension was loaded into 
a well containing a Caco-2 cell monolayer and incubated for 2 h at 37ºC in a 
5% CO2/95% air. The medium was then aspirated and Caco-2 cells were 
washed three times with PBS to remove non-adherent LAB. DMEM contain-
ing 10 mg tetracycline/ml was added to the well and incubated for another 2 
h to kill the adherent LAB. The Caco-2 cells were washed five times with 
PBS and lysed with 1% Triton X-100. Viable counts of LAB released from 
the Caco-2 cells were determined. The safety of L. reuteri was expressed as 
the invasion rate and calculated as follows:
Invasion rate (%) = 
Statistical analysis. Statistical differences between samples were de-
termined using Statistical Analysis System software (version 9.2, 2008). 
Duncan’s new multiple range test, Dunnett’s test of the GLM, and Student’s 
t-test were used to determine significance, defined as a P < 0.05.
Results
Microscopy of the gel beads and encapsulated 
cells. Figure 1 shows the scanning electron micrographs of 
the internal and external structures of the Ca-alginate (Fig. 1A, 
B), the chitosan-Ca-alginate (Fig. 1C,D) gel beads and the re-
spective encapsulated L. reuteri cells. Rod-shaped L. reuteri 
spread throughout the gel beads of both encapsulation matrices 
but the density of bacteria was lower on the surface of the chi-
tosan-Ca-alginate beads than on the surface of the Ca-alginate 
beads. By more effectively encapsulating LAB cells, chitosan-
Ca-alginate may better protect cells from unfavorable environ-
mental conditions. 
No. of adherent LAB (CFU/ml)
No. of LAB added to each well (CFU/ml)
× 100%
No. of LAB released from Caco-2 cells (CFU/ml)
No. of LAB added to each well (CFU/ml)
× 100%
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Protection of Lactobacillus reuteri by encapsu-
lation against simulated digestive juice. Table 1 
shows the viable counts (log CFU/ml) of encapsulated and 
free L. reuteri after treatment first with an acid solution of pH 
2 or 3, then with different concentrations of bile salt for 3 h, 
and then with simulated colon fluid for 1 h. LAB survival in-
creased with increasing pH and lower bile salt concentrations. 
No viable counts were found for groups F and A group at pH 
2 in combination with any of the bile salt concentrations. By 
contrast, under the same treatment conditions, a portion of the 
cells in the CA group survived. The viable counts of the CA 
group were the highest among the free and encapsulated 
groups. These results demonstrated that encapsulation im-
proves the survival of L. reuteri after acid and bile salt treat-
ments, with CA having a significantly better protective effect 
(P < 0.05). 
Table 1. Viable counts (log CFU/ml*) of encapsulated and free Lactobacillus reuteri pre-treated with a pH 2 or 3 solution for 3 h, then with 0.1, 0.5, or 
1% bile salt for 3 h, and finally with simulated colonic fluid for 1 h
Cell treatment
Initial bacteria 
count
(log CFU/ml)
pH 2 pH 3
0.1% bile 0.5% bile 1% bile 0.1% bile 0.5% bile 1% bile
Free cells (control) 8.83 ± 0.07 NDbx NDbx NDbx 3.14 ± 0.02cx 1.22 ± 0.07cy 1.00 ± 0.00cy
Alginate-coated 8.83 ± 0.07 NDbx NDbx NDbx 5.70 ± 0.08bx 3.72 ± 0.05by 3.15 ± 0.02by
Chitosan-Ca-alginate-coated 8.83 ± 0.07 2.62 ± 0.07ax 2.07 ± 0.07ay 1.40 ± 0.07az 5.96 ± 0.067ax 3.99 ± 0.09ay 3.37 ± 0.08ay
*One ml of an equal volume of LAB and aseptic water (free LAB) or LAB and Na-alginate (encapsulated LAB).
a-cDifferent letters within the same column differ significantly (P < 0.05; n = 3).
x-zDifferent letters within a row of the same pH values differ significantly (P < 0.05; n = 3).
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Fig. 1. Scanning electron micrograph of gel beads containing encapsulated Lactobacillus reuteri cells (5000× magnification). 
(A) Internal and (B) external structure of a Ca-alginate gel bead. (C) Internal and (D) external structure of a chitosan-Ca-alginate 
gel bead. Scale bar 1 µm.
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β-Galactosidase activity of encapsulated 
Lacto bacillus reuteri exposed to simulated di-
gestive juice. Table 2 shows the β-galactosidase activity 
(μmol/10 min/ml) of encapsulated and free L. reuteri after 
exposure of the cells to simulated gastrointestinal conditions. 
As evidenced by the activity values, injury of the L. reuteri 
cell membrane increased with increasing bile salt concentra-
tions at the same pH value. At pH 3, encapsulated cells of the 
A and CA groups had significantly lower β-galactosidase ac-
tivity than did the free cells. 
Adhesion of encapsulated Lactobacillus reuteri 
after simulated digestive juice treatment. The 
adherence rates of encapsulated and free L. reuteri after treat-
ment with simulated gastrointestinal conditions are shown in 
Table 3. L. reuteri cells sequentially exposed to pH 3, 0.1% 
bile salt, and simulated colonic fluid retained their adhesion 
ability, with the adhesion of the CA group (0.524%) > A group 
(0.360%) > F group (0.275%). Thus, the encapsulated cells 
were more adhesive than the free cells. 
Antagonistic activity toward Listeria mono ­
cytoge nes. Figure 2 shows the displacement effect of L. 
reuteri on FITC-labeled List. monocytogenes previously ad-
hered to Caco-2 cells. The corresponding fluorescence mi-
croscopy photographs are shown in Fig. 3. After treatment 
with simulated gastrointestinal conditions, all three groups of 
L. reuteri were able to displace List. monocytogenes. The ad-
herence rate (%) of the LAB-free group in the absence of L. 
reuteri cells was designated as 100%. After the addition of 
LAB cells of the F, A, and CA groups to pre-adhered List. 
monocytogenes, adherence of the pathogen was reduced to 
93.61%, 69.63%, and 67.02%, respectively. Thus, after se-
quential acid and bile treatments, the antagonism of List. 
monocytogenes adhered to Caco-2 cells was significantly 
greater by the encapsulated cells than by free L. reuteri (P < 
0.05). The fluorescence images in Fig. 3 qualitatively confirm 
these results, as the density of List. monocytogenes lumines-
cence was progressively reduced from the F group to the A 
group and the CA group (Fig. 3). 
Safety of Lactobacillus reuteri after simulated 
digestive juice treatment. The invasion rates of en-
capsulated and free L. reuteri after exposure of the cells to 
simulated gastrointestinal conditions were zero in all cases. 
The lack of invasiveness means that, after acid and bile salt 
treatments, LAB are recognized as safe in vitro.
Discussion
To achieve the health benefits of dietary probiotics, the food 
product should contain at least 107 live organisms per gram or 
milliliter [33,43]. Encapsulation improves the survival of pro-
Table 2. β-Galactosidase activity (μmol/10 min/ml) of encapsulated and free Lactobacillus reuteri pre-treated with a pH 2 or 3 solution for 3 h, then with 
0.1, 0.5, or 1% bile salt for 3 h, and finally with simulated colonic fluid for 1 h
Cell treatment Blank*
pH 2 pH 3
0.1% bile 0.5% bile 1% bile 0.1% bile 0.5% bile 1% bile
Free cells (control) 0.066x 0.008bx 0.013bx 0.052bx 1781.769ax 194176.592ay 338656.801az
Alginate-coated 0.066x 0.023bx 0.095bx 0.160bx 16.850bx 1906.229by 7585.133bz
Chitosan-Ca-alginate-coated 0.066x 558.554ax 6780.474ay 58144.768az 9.668bx 964.351bx 4530.215bxy
*Blank: β-galactosidase activity of cells not exposed to acid, bile salt and simulated colonic fluid.
a-bDifferent letters within the same column differ significantly (P < 0.05; n = 3).
x-zDifferent letters within the same row differ significantly (P < 0.05; n = 3).
Table 3. Adherence rates (%) of encapsulated and free Lactobacillus reuteri cells after their exposure to 
simulated gastrointestinal conditions
Cell treatment Adherence rate (%)
Free cells 0.275a
Alginate-coated 0.360b
Chitosan-Ca-alginate-coated 0.524c
a-cMeans followed by different superscript lowercase letters differ significantly from each other (P < 0.05: n = 3).
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biotic microorganisms during both food processing and pas-
sage through the gastrointestinal tract [35,13]. The protective 
effects of the Ca-alginate encapsulation of probiotics against 
the action of simulated gastric acid and bile salt have been 
reported previously [13,25]. However, bacterial viability var-
ies depending on the encapsulation method, wall material, and 
probiotic strains. Ca-alginate beads with and without chitosan 
coating have been used to encapsulate Lactobacillus acidoph-
ilus 547, Bifidobacterium bifidum ATCC 1994, and L. casei 
01, and the survival advantage conferred by the encapsulation 
of probiotics when subjected to simulated gastrointestinal 
conditions have been investigated [22]. The results of those 
studies were similar to those of the present study of L. reuteri, 
as they also demonstrated the superiority of chitosan-coated 
alginate beads in protecting against the action of acid and bile 
salt. 
The acid and bile tolerance properties of LAB have been 
investigated in several in vitro studies [13,31,49]. In most 
cases, acid and bile tolerance were examined and reported 
separately; however, these conditions do not resemble those 
of the human gastrointestinal tract [2,7], where ingested LAB 
first pass through the highly acidic environment of the stom-
ach, are then transported along the small intestine, and finally 
colonize the colon [30,37]. Thus, simulated gastrointestinal 
conditions in vitro studies should be based on the sequential 
exposure of LAB to acid and bile [25]. In this study, L. reuteri 
encapsulated using Ca-alginate and chitosan-Ca-alginate 
were treated sequentially with acid and bile salt before being 
released into simulated colonic fluid. In agreement with previ-
ous reports [22,25], the results showed that the viability of 
encapsulated L. reuteri, especially those in the CA group, was 
significantly greater than that of the free cells (Table 1). Thus, 
encapsulation can protect probiotics from the detrimental ef-
fects of the harsh conditions of the gastrointestinal tract.
Because the L. reuteri tolerance tests were conducted im-
mediately after the beads had been prepared, most of the LAB 
cells were still encapsulated inside the Ca-alginate or chito-
san-Ca-alginate matrix. During their brief, sequential acid and 
bile salt treatments, there was little release of the encapsulated 
LAB cells, as confirmed by the fact that no live L. reuteri cells 
were detected in the acid or bile salt solutions even under the 
mildest conditions (data not shown).
Injury to the bacterial cells was monitored based on the 
action of β-galactosidase, located on the inner membrane of 
LAB. ONPG (o-nitrophenyl-β-galactoside) is a colorless sub-
strate analog for the detection of β-galactosidase activity. 
When the cell membrane is injured, causing permeability to 
rise, ONPG enters the cell and reacts with β-galactosidase to 
produce the yellow-colored o-nitrophenol (ONP), which can 
be quantified by colorimetric assay. In a previous study, the 
simulated intestinal juice of oxgall increased cellular perme-
ability and therefore β-galactosidase activity [32]. In this 
study, β-galactosidase activity increased with increasing bile 
salt concentrations whether at pH 2 or pH 3. Encapsulated L. 
reuteri and especially in the CA group had the lowest 
β-galactosidase activity at pH 3. 
Since the first step in microbial colonization, and therefore 
the initiation of health benefits, is adherence to the intestinal 
surfaces, measurements of adhesiveness are essential in pro-
biotic screening [15]. The adhesiveness of probiotics as well 
as pathogens reflects the characteristic of the bacterial cell 
surface [1] and involves receptors on the surface of the host 
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Fig. 2. Displacement by Lactobacillus reuteri of pre-adhered and FITC-
labeled Listeria monocytogenes from Caco-2 cells. a-c Groups with different 
letters differ significantly from each other (P < 0.05). LAB-free group: 
pathogen adhesion in the absence of L. reuteri; F group: non-encapsulated, 
free L. reuteri cells; A group: Ca-alginate encapsulated L. reuteri cells; CA 
group: chitosan-Ca-alginate encapsulated L. reuteri cells.
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intestinal cells [29]. In the case of LAB, adherence to human 
intestinal mucosa requires extracellular glycoprotein or pro-
tein structures on the bacterial cell surface [39,46]. Accord-
ing to the adherence rates in Table 3, both released and free 
L. reuteri subjected to simulated gastrointestinal conditions 
retained their ability to adhere to Caco-2 cells, with the re-
leased encapsulated L. reuteri displaying greater adhesiveness 
than free cells. This result suggests that encapsulation should 
protect cell surface factors such as proteins or carbohydrates 
from the injury caused by acid and bile salt and thus would 
maintain bacterial adhesiveness.
Inhibition of the adhesion of pathogens to intestinal epi-
thelial cells by LAB has been demonstrated in vivo [3,26] and 
may be related to competition for specific adhesion receptors 
on the surface of gut cells [27]. Another study [9] has found 
that reuterin, produced by L. reuteri, inhibits both Gram-
positive and Gram-negative bacteria. The inhibition of Heli-
co bacter pylori by L. reuteri was proposed to involve bacte-
riostatic activity, the production of inhibitory compounds 
such as lactate and bactericidal substances, competition for 
nutrients, immunostimulation of mucosal IgA production, 
and/or the adherent capacity of L. reuteri to epithelial cells 
[12]. In this study, pathogen displacement from the intestinal 
surface was modeled using Caco-2 cells incubated first with 
List. monocytogenes and then with LAB previously exposed 
to simulated gastrointestinal conditions. Pathogen adherence 
was significantly reduced by cells in both the free and encap-
sulated groups, with the latter having a more potent effect. 
In a previous study, we investigated the adhesion inhibi-
tion and displacement abilities of three LAB strains 
(Lactobacillus acidophilus BCRC 10695, L. paracasei BCRC 
14023, Bifidobacterium bifidum BCRC 14615) using the 
pathogen Clostridium perfringens BCRC 13019 [16]. The ad-
hesion inhibition test measured the ability of LAB cells pre-
adhered to Caco-2 cells to inhibit the adhesion of C. perfrin-
gens. The displacement assay examined the displacement ef-
fect of LAB cells pretreated or not with acid and bile salt. 
Because the experimental design used in the present work 
sought to mimic the conditions of the gastrointestinal tract, 
only the displacement assay was performed and the antago-
nistic ability of encapsulated and free L. reuteri cells after se-
quential acid and bile salt treatments was compared. The re-
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Fig. 3. Fluorescence microscopy photographs showing the displacement of pre-adhered and FITC-labeled Listeria 
monocytogenes by Lactobacillus reuteri. (A) LAB-free group; (B) free L. reuteri cells (F group); (C) Ca-alginate group 
(A group); (D) chitosan-Ca-alginate group (CA group).
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sults confirmed the protective effect of encapsulation based 
on the lower adherence rates of List. monocytogenes achieved 
with A and CA group cells than with F group cells (Fig. 2). 
The invasion assay was used to determine the infectivity 
and pathogenicity of the tested LAB, as previously described 
[44]. LAB are generally recognized as safe for multiple uses. 
The health benefits of L. reuteri based on their colonization of 
the gastrointestinal tract and immunomodulation have been 
reported [47] and their daily ingestion is safe, with no nega-
tive side effects [6,48]. The safety of L. reuteri BCRC strain 
14625 used in this research had been previously demonstrated 
[5] and was confirmed in this study by the absence of invasion 
by free or released cells exposed to acid (pH 3) and then bile 
salt (0.1%). 
In summary, this study investigated the protective effects 
of Ca-alginate and chitosan-Ca-alginate encapsulation of 
L. reuteri, and the remaining probiotic properties of the re-
leased bacteria after their sequential exposure to simulated 
gastrointestinal conditions. The results showed that, com-
pared to free (non-encapsulated) cells, encapsulation, espe-
cially using chitosan-Ca-alginate gel beads, improves the sur-
vival of acid- and bile-salt-treated L. reuteri, reduces injury to 
the cell membrane, and preserves the probiotic properties of 
adhesiveness and pathogen antagonism. Our method of chal-
lenging gel-encapsulated lactic acid bacteria with sequential 
simulated acid and bile salt treatment is a suitable approach to 
investigating their potential probiotic properties [16].
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